First Bancorp’s AbbVie ABBV Stock Holding History

First Bancorp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$825K	Buy	3,278 +303	+10%	+$65.2K	0.33%	56
2026 Q1	$647K	Sell	2,975 -55	-2%	-$12.2K	0.32%	62
2025 Q4	$692K	Sell	3,030 -202	-6%	-$46K	0.37%	59
2025 Q3	$748K	Buy	3,232 +215	+7%	+$43.8K	0.4%	56
2025 Q2	$560K	Buy	3,017 +779	+35%	+$145K	0.32%	70
2025 Q1	$469K	Buy	2,238 +2	+0.1%	+$389	0.3%	71
2024 Q4	$397K	Sell	2,236 -4	-0.2%	-$735	0.27%	80
2024 Q3	$442K	Buy	2,240 +56	+3%	+$10.5K	0.31%	77
2024 Q2	$375K	Hold	2,184	–	–	0.28%	83
2024 Q1	$398K	Sell	2,184 -9	-0.4%	-$1.55K	0.3%	77
2023 Q4	$340K	Buy	2,193 +40	+2%	+$5.83K	0.27%	83
2023 Q3	$321K	Buy	2,153 +100	+5%	+$14.7K	0.28%	76
2023 Q2	$277K	Sell	2,053 -110	-5%	-$16.1K	0.23%	89
2023 Q1	$345K	Buy	2,163 +323	+18%	+$49.4K	0.3%	76
2022 Q4	$297K	Sell	1,840 -66	-3%	-$10.1K	0.25%	79
2022 Q3	$256K	Sell	1,906 -20	-1%	-$2.87K	0.23%	88
2022 Q2	$295K	Sell	1,926 -525	-21%	-$80.2K	0.28%	77
2022 Q1	$398K	Sell	2,451 -109	-4%	-$15.8K	0.36%	57
2021 Q4	$346K	Buy	2,560 +66	+3%	+$7.8K	0.3%	65
2021 Q3	$269K	Buy	+2,494	New	+$285K	0.26%	82
2021 Q1	$277K	Buy	+2,562	New	+$274K	0.27%	75

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

First Bancorp's ABBV Position: Q2 2026 in Review

First Bancorp increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $65.2K and bringing the position to 3,278 shares worth $825K. The position accounts for 0.33% of the portfolio, ranked #56.

First Bancorp first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

First Bancorp held 3,278 shares of AbbVie worth $825K as of Q2 2026.
First Bancorp bought 303 AbbVie shares in Q2 2026, an estimated $65.2K.
AbbVie made up 0.33% of First Bancorp's portfolio in Q2 2026, its #56 holding.
First Bancorp first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Bancorp's 13F filing for Q2 2026, filed 11 Aug 2026.